Trending

HarmonyCVI, an AI-ML-based Cardiac MRI Diagnostics Tool

HarmonyCVI, the flagship product of iHridAI, an up-and-coming healthcare technology firm devoted to creating commercially feasible and internationally benchmarked technological solutions for healthcare diagnostics, was introduced today. HarmonyCVI provides thorough and precise cardiovascular examinations.iHridAI's HarmonyCVI is an AI-ML-based diagnostic tool the volt post

A complete AI/ML-based tool for fast diagnoses and insights, HarmonyCVI helps radiologists and cardiologists analyse cardiac MRI data more effectively.

HarmonyCVI makes use of deep learning AI/ML capabilities and is based on solid research, cardiothoracic models, and a large amount of real-world cardiac imaging data.

The patient’s MRI studies are input, relevant metrics are learned, and a variety of characteristics, such as dynamic contours and segmentation, are predicted. The programme uploads its thorough results of processing and analysis into reports on clinical data that are editable and watched on a dashboard.

With the use of the technological solution, cardiologists and radiologists may make decisions quickly and intelligently—usually in a matter of minutes—by providing them with precise and clinically trustworthy information.

In order to facilitate practical evaluation and treatment, HarmonyCVI enables doctors to rapidly evaluate the critical factors for a thorough diagnosis. Real-time interactive report production with automatic report data analysis in the required format is provided by the integrated platform.

Commenting on the launch, Sai Sangineni, Founder, iHridAI said, “Resonating with the vision to create globally benchmarked AI-based healthcare solutions, we launched HarmonyCVI for the clinical community. The tool is fundamentally designed to enhance the accessibility, accuracy and affordability of real-world cardiac MRI diagnostics. Using these comprehensive and detailed insights, patients with critical cardiac MRIs can be triaged for advanced and accurate review and assessed treatments. The core of our innovation addresses the need for cost effective PAR for the growing cardiac MRI adoption. At iHridAI, we strive forward to align with the new realities of preventive patient care using AI and continue to develop value-based solutions for the larger medical fraternity.”

Dr. Vimal Raj, Clinical Advisor and Co-founder, iHridAi further adds, “The launch of HarmonyCVI reinforces our commitment towards curating an AI-based solution for analyzing cardiac MRI scans rapidly. While the PAR (processing, analyzing and reporting) for ECG, CT, PET and other MRIs is straightforward today, the complex cardiac MRIs need a vendor-agnostic, economically viable, easy-to-deploy solution to drive the adoption and further growth of cardiac MRI usage in advanced heart diagnostics. Harmony CVI is easy to learn, deploy and use. The user interface, speed, precision and diagnostic accuracy will help physicians with early diagnosis, thus improving better clinical outcomes of patients.

By utilising partners and suppliers for advanced and complementary domain expertise and solution engineering, iHridAI is promoting a collaborative approach.

Among them are eminent radiologists, investigators, and specialists in medical imaging/AI. The first product introduced into this ecosystem is HarmonyCVI, which has undergone extensive testing and validation using a significant number of real-world datasets from diverse sources. In parallel, iHridAI is attempting to create a single, comprehensive AI analytics platform that encompasses CT, MRI, ECG, and ECHO.

Don't Miss